NCBS Home page
Accession List
Pathway List
Search
Authorized Users
Help
News archives

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.
Search in: Search for Match By

Molecule Parameter List for Ser845-P

The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network.
The text color of a molecule is highlighted by color.
Statistics
Ser845-P participated asMoleculeSum total ofEnzymeSubstrate of an enzymeProduct of an enzymeSubstrate in ReactionProduct in Reaction
No. of occurrences1200000

Accession and Pathway Details
Accession NameAccession No.Accession TypePathway Link
  • AMPAR_traff_
    model1
  • 60Network
    Shared_Object_AMPAR_traff_model1 CaMKII CaM 
    PP1 PP2B PP1_PSD 
    PKA AC AMPAR 
    AMPAR_memb 
    This is the basic model of AMPAR trafficking bistability. It is based on Hayer and Bhalla, PLoS Comput. Biol. 2005. It includes the degradation and turnover of AMPARs. The CaMKII portion of the model is not bistable.

    Ser845-P acting as a Molecule in  
    AMPAR_traff_model1 Network
    NameAccession NamePathway NameInitial Conc.
    (uM)
    Volume
    (fL)
    Buffered
    Ser845-P
  • AMPAR_traff_
    model1

    Accession No. : 60
  • AMPAR_memb
    Pathway No. : 253
    00.01No

    Ser845-P acting as a Summed Molecule in  
    AMPAR_traff_model1 Network
     Accession NanePathway NameTargetInput
    1
  • AMPAR_traff_
    model1

    Accession No. : 60
  • AMPAR_memb
    Pathway No. : 253
    Ser845-PA845*_B
    A831*845*_B
    A845*_B831*
    A831*845*_B831*
    A_B845*
    A831*_B845*
    A_B831*845*
    A831*_B831*845*
    2
  • AMPAR_traff_
    model1

    Accession No. : 60
  • AMPAR_memb
    Pathway No. : 253
    tot_mem_GluR12Ser845
    Ser845-P
    Ser845-PP



    Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
    This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.